The offering is priced and expected to close imminently. Monitor for further capital raises given the company's pre-revenue status and history of frequent offerings. The $12.00 warrant exercise price may create overhang if the stock trades below that level.
Price Chart
Executive Summary
Polyrizon Ltd. filed a 6-K disclosing a securities purchase agreement for a registered direct offering of up to approximately $4.0 million in ordinary shares and warrants at $12.00 per unit, with concurrent PIPE warrants exercisable at $12.00 for five years. This is a dilutive capital raise for a pre-revenue development-stage biotech with a history of frequent offerings, reinforcing the bearish view from the same-day 424B5 filing.
Key Facts
- Securities purchase agreement for up to ~$4.0 million in shares and warrants at $12.00 per unit.
- Includes PIPE common warrants exercisable at $12.00 with a 5-year term.
- Lock-up agreements with directors, officers, and 10%+ shareholders.
- Net proceeds to be used for general corporate purposes and working capital.
- Placement agent is Aegis Capital Corp.
Financial Impact
Dilutive capital raise of up to $4.0 million, representing approximately 12-15% dilution based on prior offering structure.
Risk Factors
- Significant dilution to existing shareholders from this and prior offerings.
- Pre-revenue development-stage biotech with uncertain cash runway.
- Potential for additional dilutive financings given history of 16 offering filings in 24 months.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-097444 |
| Document: ea030232201ex10-2.htm | 0001213900-26-097444 |
| Document: ea030232201ex10-6.htm | 0001213900-26-097444 |
| Document: ea030232201ex10-5.htm | 0001213900-26-097444 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $9.01 | awaiting T+1 | — | $8.58 (−4.77%) |
Oct 27, 2026 today | Press Release | $9.01 | awaiting T+1 | — | $8.58 (−4.77%) |
Oct 5, 2026 22d ago | 6-K | $9.67 $9.15 | ▼ −5.37% | ▼ −5.13% | $8.58 (−11.27%) |
Oct 2, 2026 25d ago | EFFECT | $9.61 $9.26 | ▲ +3.64% | ▲ +4.32% | $8.58 (+10.72%) |
Sep 22, 2026 5w ago | Press Release | $10.66 $11.16 | ▲ +4.69% | ▲ +5.41% | $8.58 (−19.51%) |
Sep 18, 2026 5w ago | F-1 | $10.90 $10.66 | ▲ +2.20% | ▲ +2.19% | $8.58 (+21.28%) |
Sep 4, 2026 7w ago | Press Release | $11.24 $11.15 | ▲ +0.80% | ▲ +0.25% | $8.58 (+23.67%) |
Sep 4, 2026 7w ago | 6-K | $11.24 $11.15 | ▲ +0.80% | ▲ +0.25% | $8.58 (+23.67%) |
Sep 4, 2026 7w ago | 424B5 | $11.24 $11.15 | ▲ +0.80% | ▲ +0.25% | $8.58 (+23.67%) |
Aug 20, 2026 9w ago | 6-K | $10.30 $10.70 | ▲ +3.88% | ▲ +4.18% | $8.58 (−16.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers